118 related articles for article (PubMed ID: 38484829)
1. Spironolactone metabolite causes falsely increased progesterone in the Abbott Architect immunoassay.
Sarpong KAN; Hee Kim S; McCartney CR; Wiencek JR; Bazydlo LAL
Clin Biochem; 2024 Apr; 126():110747. PubMed ID: 38484829
[TBL] [Abstract][Full Text] [Related]
2. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
DeFrance A; Armbruster D; Petty D; Cooper KC; Dasgupta A
Ther Drug Monit; 2011 Feb; 33(1):128-31. PubMed ID: 21079546
[TBL] [Abstract][Full Text] [Related]
3. Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
Dasgupta A; Tso G; Wells A
Ther Drug Monit; 2008 Dec; 30(6):744-7. PubMed ID: 18824952
[TBL] [Abstract][Full Text] [Related]
4. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
Steimer W; Müller C; Eber B
Clin Chem; 2002 Mar; 48(3):507-16. PubMed ID: 11861441
[TBL] [Abstract][Full Text] [Related]
5. A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone.
Dasgupta A; Kang E; Datta P
J Clin Lab Anal; 2006; 20(5):204-8. PubMed ID: 16960898
[TBL] [Abstract][Full Text] [Related]
6. Clinically insignificant negative interferences of spironolactone, potassium canrenoate, and their common metabolite canrenone in new dimension vista LOCI digoxin immunoassay.
Dasgupta A; Johnson MJ; Sengupta TK
J Clin Lab Anal; 2012 May; 26(3):143-7. PubMed ID: 22628228
[TBL] [Abstract][Full Text] [Related]
7. Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
Dasgupta A; Johnson MJ
J Clin Lab Anal; 2010; 24(6):413-7. PubMed ID: 21089173
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin.
Dasgupta A; Saffer H; Wells A; Datta P
J Clin Lab Anal; 2002; 16(4):172-7. PubMed ID: 12112389
[TBL] [Abstract][Full Text] [Related]
9. A new turbidometric digoxin immunoassay on the ADVIA 1650 analyzer is free from interference by spironolactone, potassium canrenoate, and their common metabolite canrenone.
Datta P; Dasgupta A
Ther Drug Monit; 2003 Aug; 25(4):478-82. PubMed ID: 12883233
[TBL] [Abstract][Full Text] [Related]
10. Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays.
Pleasants RA; Williams DM; Porter RS; Gadsden RH
Ther Drug Monit; 1989; 11(2):200-4. PubMed ID: 2655203
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
[TBL] [Abstract][Full Text] [Related]
12. Influence of spironolactone and its metabolite canrenone on serum digoxin assays.
Foukaridis GN
Ther Drug Monit; 1990 Jan; 12(1):82-4. PubMed ID: 2305425
[TBL] [Abstract][Full Text] [Related]
13. Can Measurement of Progesterone, Estradiol, and Prolactin by Immunoassay be Interchanged? A Comparison of the Roche Cobas e601 vs. Abbott Architect i2000sr.
Yin L; Chen X; Tang Y; Sun Y
Clin Lab; 2017 Mar; 63(3):569-577. PubMed ID: 28271677
[TBL] [Abstract][Full Text] [Related]
14. A comparison between two different automated total 25-hydroxyvitamin D immunoassay methods using liquid chromatography-tandem mass spectrometry.
Kocak FE; Ozturk B; Isiklar OO; Genc O; Unlu A; Altuntas I
Biochem Med (Zagreb); 2015; 25(3):430-8. PubMed ID: 26526462
[TBL] [Abstract][Full Text] [Related]
15. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
Gray MA; Cooke RR; Weinstein P; Nacey JN
Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
[TBL] [Abstract][Full Text] [Related]
16. Effects of serum indices interference on hormonal results from the Abbott Architect i2000 immunoassay analyser.
Hasanato R; Brearton S; Alshebani M; Bailey L; Aldugashim S; Alothaim A; Tamimi W
Br J Biomed Sci; 2015; 72(4):151-5. PubMed ID: 26738394
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of Two Progesterone Immunoassays for Monitoring In Vitro Fertilization.
Roper SM; Rubin JR; Ali M; Gibbons WE; Zarutskie PW; Devaraj S
J Appl Lab Med; 2018 Mar; 2(5):770-776. PubMed ID: 33636866
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Three Immunoassays Systems for Determining Serum Estradiol.
Zhang H; Huang Y; Liang K
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969070
[TBL] [Abstract][Full Text] [Related]
19. Intoxication due to negative canrenone interference in digoxin drug monitoring.
Steimer W; Müller C; Eber B; Emmanuilidis K
Lancet; 1999 Oct; 354(9185):1176-7. PubMed ID: 10513714
[TBL] [Abstract][Full Text] [Related]
20. Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies.
Hager HB; Bolstad N; Warren DJ; Ness MV; Seierstad B; Lindberg M
Clin Chem Lab Med; 2021 Mar; 59(4):663-669. PubMed ID: 33119540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
